IHL 0.00% 4.1¢ incannex healthcare limited

Ann: Independent data review commences for Ph 2 trial psilocybin, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 412 Posts.
    lightbulb Created with Sketch. 418
    Sounds to me like it is progressing extremely well, they are intending to do the full 72 patient trial based on current results.
    It’s not cheap to run a trial like this so the fact it is continuing is a big plus. It does have steps that do have to be followed hence the independent review.
    Very promising.
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.